CVS Health price target raised to $89 from $82 at Morgan Stanley

Group 1 - Morgan Stanley analyst Erin Wright raised the price target on CVS Health (CVS) to $89 from $82, maintaining an Overweight rating on the shares [1] - Last week's Stars results were described as "encouraging" for the sector, indicating a positive sentiment shift [1] - Managed Care Organization sentiment has "improved slightly," but there remains a need for further validation as focus shifts to utilization and early insights on 2026 [1]